Effect of the therapeutic effect of chromium supplementation with doses of 400 and 600 micrograms on body mass index

Effect of the therapeutic effect of chromium supplementation with doses of 400 and 600 micrograms on body mass index, insulin sensitivity and depression, anxiety and stress in polycystic ovary syndrome

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210515051298N1

Enrollment

120

Registered

2021-08-09

Start date

2021-06-22

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovarian syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group 1: Chromium supplement 400 micrograms of CENTURY company daily orally for two months. Intervention 2: Intervention group 2: Chromium supplement 600 micrograms daily

Eligibility

Sex/Gender

Female

Age

16 Years to 40 Years

Inclusion criteria

Inclusion criteria: Satisfaction of patients aged 16 to 40 years Polycystic Ovary Syndrome

Exclusion criteria

Exclusion criteria: Take chromium picolinate supplement regularlyHydroxy Progesterone above 2

Design outcomes

Primary

Measure	Time frame
Body mass index. Timepoint: Two months after the start of the intervention. Method of measurement: Questionaire.;Insulin sensitivity. Timepoint: Two months after the start of the intervention. Method of measurement: Questionaire.;Depression. Timepoint: Two months after the start of the intervention. Method of measurement: Questionaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBelghese Mohammadi

Shahre-kord University of Medical Sciences

mohammadi.b@skums.ac.ir+98 38 3222 0016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026